Bradykinin-induced vasodilation of human coronary arteries in vivo: Role of nitric oxide and angiotensin-converting enzyme

Journal of the American College of Cardiology

Volumn 30, Issue 1, 1997, Pages 108-112

  Kuga, Takeshi ^a   Mohri, Masahiro ^a   Egashira, Kensuke ^a   Hirakawa, Yoji ^a   Tagawa, Tatsuya ^a   Shimokawa, Hiroaki ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRILAT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PAPAVERINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; ENZYME INHIBITION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; VASODILATATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; ENALAPRILAT; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PEPTIDYL-DIPEPTIDASE A; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, INTERVENTIONAL; VASODILATION;

EID: 0030740673     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00112-5     Document Type: Article

References (20)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the regulation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
3. Oza NB, Schwartz JH, Gould HD, Levinsky NG. Rat aortic smooth muscle cells in culture express kallikrein kininogen and bradykininase activity. J Clin Invest. 85:1990;597-600.
4. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 32:1990;1-46.
5. Richard V, Tanner F, Tschudi M, Lüscher TF. Different activations of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol. 259:1990;H1433-H1439.
6. Tschudi M, Richard V, Bühler FR, Lüscher TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol. 260:1991;H13-H20.
7. Pelc LR, Gross GJ, Warltier D. Mechanisms of coronary vasodilation produced by bradykinin. Circulation. 83:1991;2048-2056.
8. Mombouli JV, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxation to bradykinin by angiotensin 1-converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 71:1992;137-144.
9. Mombouli JV, Vanhoutte PM. Heterogeneity of endothelium-dependent vasodilator effect of angiotensin-converting enzyme inhibitors role of bradykinin generation during ACE inhibition . J Cardiovasc Pharmacol. 20:(Suppl 9):1992;S74-S83.
10. Zanzinger J, Zheng X, Bassenge E. Endothelium-dependent vasomotor responses to endogenous agonist are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res. 28:1994;209-214.
11. Kuga T, Egashira K, Mohri M, et al. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation. 92:1995;183-189.
12. Groves P, Kurz S, Just H, Drexler H. Role of bradykinin in human coronary vasomotor control. Circulation. 92:1995;3424-3430.
13. Erdös EG. Angiotensin-converting enzyme and the change in our concept through the years. Hypertension. 26:1990;363-370.
14. Egashira K, Inou T, Hirooka Y, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factor and proximal atherosclerotic lesions. J Clin Invest. 91:1993;29-37.
15. Egashira K, Katsuda Y, Mohri M, et al. Role of endothelium-derived nitric oxide in coronary vasodilation induced by pacing tachycardia in humans. Circ Res. 79:1996;331-335.
16. Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation impact of risk factors for coronary atherosclerosis . J Clin Invest. 95:1995;1747-1755.
17. Sudhir K, Chou TM, Hutchinson SJ, Chatterjee K. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo differential contribution of nitric oxide and bradykinin in conductance and resistance arteries . Circulation. 93:1996;1734-1739.
18. Olmos L, Mombouli JV, Illiano S, Vanhoutte PM. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol. 268:1995;H865-H870.
19. Rafflenbeul W, Bassenge E, Lichtlen P. Competition between endothelium-dependent and nitroglycerin-induced coronary vasodilation. Zeitschrift fur Kardiologie 1989;78 Suppl 2:45-7; discussion 64-67.
20. Mancini GBJ, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease the TREND study . Circulation. 94:1996;258-265.